Presentation is loading. Please wait.

Presentation is loading. Please wait.

Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease  Peter Borger, PhD,

Published byBertina Rodgers Modified over 5 years ago

Similar presentations

Presentation on theme: "Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease  Peter Borger, PhD,"— Presentation transcript:

1 Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease  Peter Borger, PhD, Hisako Matsumoto, PhD, Sarah Boustany, Mikael M.C. Gencay, PhD, Janette K. Burgess, PhD, Greg G. King, MD, Judith L. Black, PhD, MBBS, FRACP, Michael Tamm, MD, Michael Roth, PhD  Journal of Allergy and Clinical Immunology  Volume 119, Issue 1, Pages (January 2007) DOI: /j.jaci Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 A, Histology and immunohistochemistry of C/EBPα of bronchial tissue sections. Top panel, Routine histologic examination of nonasthmatic and asthmatic airway sections demonstrates an increase in the size of the BSMC layer (hematoxylin and eosin staining, original magnification ×160). Middle panel, Immunohistochemical staining with a C/EBPα-specific antibody detected with fluorescein isothiocyanate–labeled secondary antibody. Bottom panel, Staining with the secondary antibody demonstrates the specificity of the signal. ASM, airway smooth muscle. B, Immunohistochemistry of C/EBPα in bronchial tissue sections. Sections were obtained and immunohistochemistry was performed as described in the Methods section. Lung sections from a healthy individual and an asthmatic patient were stained in parallel with a specific C/EBPα antibody by using peroxidase-based immunohistochemical staining. Mayer's hematoxylin was used for counterstaining. Tissue sections were mounted with 60% glycerol in PBS and examined by means of light microscopy. Arrows indicate ASM bundles. C, Expression patterns of C/EBPα, β, δ, and ε in cultured BSMCs. BSMCs were cultured from lung specimens of healthy subjects, asthmatic patients, and patients with COPD (as indicated). Staining was performed with antibodies specific for C/EBPα, β, δ, and ε according to the procedure described in the Methods section. The figure is representative of 3 independent immunohistochemical staining experiments. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Immunoanalysis of C/EBPα, β, δ, and ε in cultured BSMCs. The expression of the distinct C/EBPs is variable per cell line. The upper and lower panels represent the 2 most extreme protein expression patterns of C/EBPα (A), C/EBPβ (B), C/EBPδ (C), and C/EBPε (D) observed in whole-cell lysates of cultured BSMCs of 9 healthy control subjects, 12 asthmatic patients, and 10 patients with end-stage COPD (emphysema). BSMCs were cultured in the presence or absence of 5% FBS (as indicated). The C/EBP protein expression data of all cell lines are summarized in Table I. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 C/EBPα mRNA expression in BSMC lines of a healthy control subject and 2 asthmatic patients. RT-PCR products (top) and protein (bottom) in BSMCs obtained from 1 control cell line cultured from a nonasthmatic individual (NA) and 2 cell lines cultured from 2 asthmatic subjects, 1 negative (A1) and 1 positive (A2) for C/EBPα protein expression, are shown. Cells were cultured in the absence or presence of 5% FBS (as indicated). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Representative EMSAs demonstrating C/EBP DNA-binding and supershift analysis with antibodies for C/EBPδ, C/EBPβ, and C/EBPδ+ε. Nuclear extracts were obtained from BSMC lines cultured from tissue of a healthy control subject and an asthmatic patient (A) and a healthy control subject and a patient with COPD (B). The data shown are representative of 3 independent experiments. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Effects of budesonide or formoterol alone and a combination of both drugs on C/EBP protein expression. BSMCs were obtained from control subjects (left panel), patients with COPD (middle panel), and asthmatic subjects (right panel) who expressed alternatively sized C/EBPα (middle right) or do not express C/EBPα (left panel). BSMCs were cultured without FBS, with 5% FBS, with budesonide (10−8 M), with formoterol (10−8 M), and with a combination of budesonide and formoterol (10−8 M). The data shown are representative of 5 independent experiments. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig 6 Schematic representation of the putative involvement of C/EBP proteins in the tissue-remodeling process. C/EBPα inhibits proliferation in most cells, including respiratory tissue cells, and functions as a brake for cell-cycle progression. Decreased levels of C/EBPα, as observed in the asthma group, might shift the balance in favor of increased proliferation and could potentially explain the remodeling in the asthmatic airway. On the other hand, diminished expression of the cell-cycle accelerator C/EBPδ might lead to lung tissue loss. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease  Peter Borger, PhD,"

Similar presentations

Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore–induced allergic airway disease  Ana Paula Moreira, PhD, Karen A.

Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore–induced allergic airway disease  Ana Paula Moreira, PhD, Karen A.
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,

Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Fibrocyte localization to the airway smooth muscle is a feature of asthma  Ruth Saunders, PhD, Salman Siddiqui, MRCP, Davinder Kaur, PhD, Camille Doe,

Fibrocyte localization to the airway smooth muscle is a feature of asthma  Ruth Saunders, PhD, Salman Siddiqui, MRCP, Davinder Kaur, PhD, Camille Doe,
Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris,

Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris,
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis

Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis

Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,

Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Obstructive sleep apnea syndrome and inflammation

Obstructive sleep apnea syndrome and inflammation
Tissue factor–bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo  Jin-Ah Park, PhD, Asma S.

Tissue factor–bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo  Jin-Ah Park, PhD, Asma S.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.

Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Role of airway smooth muscle in airway remodeling

Role of airway smooth muscle in airway remodeling
Airway epithelial cells in asthma

Airway epithelial cells in asthma
Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids  Kittipong Maneechotesuwan, MD, PhD, Sirinya.

Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids  Kittipong Maneechotesuwan, MD, PhD, Sirinya.
Dual nature of T cell–epithelium interaction in chronic rhinosinusitis

Dual nature of T cell–epithelium interaction in chronic rhinosinusitis
Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells  Rommy Koetzler, MD, MSc, Raza S. Zaheer,

Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells  Rommy Koetzler, MD, MSc, Raza S. Zaheer,
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,

FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
Glenn Cruse, PhD, Shailendra R. Singh, PhD, S

Glenn Cruse, PhD, Shailendra R. Singh, PhD, S
Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients  Thomas Trian,

Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients  Thomas Trian,
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.

Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?

Similar presentations

Ads by Google